These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 17144005)

  • 1. Closing the sample closet.
    Sanders J
    Fam Pract Manag; 2006; 13(10):16, 21; author reply 21. PubMed ID: 17144005
    [No Abstract]   [Full Text] [Related]  

  • 2. Closing the sample closet.
    Brewer B
    Fam Pract Manag; 2006; 13(10):16; author reply 21. PubMed ID: 17144004
    [No Abstract]   [Full Text] [Related]  

  • 3. Closing the sample closet.
    Johnson JE
    Fam Pract Manag; 2006; 13(10):16, 21; author reply 21. PubMed ID: 17144006
    [No Abstract]   [Full Text] [Related]  

  • 4. Closing the sample closet.
    Brown SR
    Fam Pract Manag; 2006; 13(10):16; author reply 21. PubMed ID: 17139936
    [No Abstract]   [Full Text] [Related]  

  • 5. Saving the sample closet.
    Taylor JA
    Fam Pract Manag; 2007 Jan; 14(1):11. PubMed ID: 17294975
    [No Abstract]   [Full Text] [Related]  

  • 6. Saying no to samples.
    Tsai A
    Med Econ; 2009 Nov; 86(22):22-4, 27. PubMed ID: 20055014
    [No Abstract]   [Full Text] [Related]  

  • 7. [Troubling shortage of drugs].
    Kiefer B
    Rev Med Suisse; 2012 May; 8(342):1144. PubMed ID: 22734188
    [No Abstract]   [Full Text] [Related]  

  • 8. Taming the sample closet.
    Cohen ML
    Fam Pract Manag; 2006 Oct; 13(9):43-6. PubMed ID: 17076110
    [No Abstract]   [Full Text] [Related]  

  • 9. Aggressive drug marketing tactics trigger backlash.
    Singer E
    Nat Med; 2007 Apr; 13(4):393. PubMed ID: 17415363
    [No Abstract]   [Full Text] [Related]  

  • 10. Friction and fact in the marketing of pharmaceuticals and biologics.
    Herrick JB
    J Am Vet Med Assoc; 1992 Aug; 201(4):556-7. PubMed ID: 1517128
    [No Abstract]   [Full Text] [Related]  

  • 11. Is your sample cabinet a danger zone?
    Lowes R
    Med Econ; 2004 May; 81(9):45-8. PubMed ID: 15164646
    [No Abstract]   [Full Text] [Related]  

  • 12. Most drug freebies go to well-off: study. Research suggests race, gender a factor, too, but drug group calls research flawed.
    Rhea S
    Mod Healthc; 2008 Jan; 38(1):12-3. PubMed ID: 18273965
    [No Abstract]   [Full Text] [Related]  

  • 13. Using drug samples can hinder quality.
    Healthcare Benchmarks Qual Improv; 2004 Mar; 11(3):34-5. PubMed ID: 15002360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unlabeled drug samples and the learned intermediary: the case for drug company liability without preemption.
    Poser S
    Food Drug Law J; 2007; 62(4):653-94. PubMed ID: 18557225
    [No Abstract]   [Full Text] [Related]  

  • 15. Global health challenges in the pharmaceutical world.
    Abraham J
    Health Econ Policy Law; 2009 Jan; 4(Pt 1):115-27. PubMed ID: 19099620
    [No Abstract]   [Full Text] [Related]  

  • 16. A change in the market--investing in diagnostics.
    Batchelder K; Miller P
    Nat Biotechnol; 2006 Aug; 24(8):922-6. PubMed ID: 16900131
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmaceuticals and medical devices: business practices.
    Jones TM
    Issue Brief Health Policy Track Serv; 2009 Jan; ():1-54. PubMed ID: 19297719
    [No Abstract]   [Full Text] [Related]  

  • 18. Marketing to the pharmacist.
    Zilz DA
    Med Mark Media; 1981 Jul; 16(7):8, 10, 14. PubMed ID: 10317131
    [No Abstract]   [Full Text] [Related]  

  • 19. Drug sample availability and prescribing behavior.
    Watts SA; Replogle WH; Noble SL; Beebe DK
    J Am Board Fam Pract; 2002; 15(6):509. PubMed ID: 12463301
    [No Abstract]   [Full Text] [Related]  

  • 20. [Pharmaceutical economics and socialist organization science. Drug marketing series. Implication of marketing in the lapse of time in drug studies].
    Alcer G
    Pharm Prax; 1970; 8():169-73. PubMed ID: 5524906
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.